Device Trial Radar · NCT05631639
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study
Last checked: Nov 20, 2026Latest source record: Nov 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
May 7, 2021
Primary completion
Jun 30, 2021
Study completion Aug 30, 2021
Sponsor
- Lead sponsor
- EnteraSense LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 30, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, prospective, non-randomized, open-label, exploratory clinical investigation performed to evaluate safety and effectiveness of the PillSense System when used for detection of blood in the stomach of patients suspected to have an Upper Gastrointestinal Bleed (UGIB).
Conditions
- Upper Gastrointestinal Bleeding
Interventions
PillSense SystemDevice
The PillSense capsule is a diagnostic capsule equipped with a sensor for in vivo detection of liquid blood and a paired PillSense receiver for result display.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device feasibilityTime frame: within 30 minutes
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Fakultní nemocnice Olomouc (FNOL)
Olomouc, Czechia
Fakultní nemocnice Ostrava (FNO)
Ostrava, Czechia
Institut klinické a experimentální medicíny (IKEM),
Prague, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.